Evidence map›Paper›PMID 32231999›Full record

ArticleFrontiers in oncology2020

MicroRNA-1224-5p Inhibits Metastasis and Epithelial-Mesenchymal Transition in Colorectal Cancer by Targeting SP1-Mediated NF-κB Signaling Pathways.

Jie Li, Wen Peng, Peng Yang, Ranran Chen, Qiou Gu, Wenwei Qian, Dongjian Ji, Qingyuan Wang, Zhiyuan Zhang, Junwei Tang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Function ofOncology letters · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Specificity Proteins (Sp) and Cancer.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. MicroRNA-4463 facilitates the development of colon cancer by suppression of the expression of PPP1R12B.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jie LiThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Wen PengThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Peng YangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Ranran ChenThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Qiou GuThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Wenwei QianThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Dongjian JiThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Qingyuan WangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Zhiyuan ZhangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Junwei TangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Yueming SunThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Jiangsu Province Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that play pivotal roles in cancer initiation and progression. However, the roles and molecular mechanisms of miRNAs in colorectal cancer (CRC) progression remain unclear. Here, we show that downregulation of miR-1224-5p in CRC is negatively correlated with SP1 expression and metastasis in patients and xenografted mouse models. Gain- and loss-of-function assays reveal that miR-1224-5p suppresses the migration, invasion, and epithelial-mesenchymal transition (EMT) of CRC cells

Indexed as

colorectal cancermetastasismiR-1224-5pNF-κBprognostic biomarkerSP1

Identifiers

PMID32231999
PMCPMC7083241
OpenAlexW3010977833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.